Regulatory & Legal20 min read
FDA Peptide Ban Lifted: 14 Peptides Reclassified in 2026
RFK Jr. announced 14 peptides are moving off the FDA's "do not compound" list. Which peptides return, which stay restricted, and what it actually means.
Regulatory & Legal
FDA, legal, and compliance content.
Regulatory & Legal15 min read
Peptide Clinical Trial Regulation: IND Process
Every FDA-approved peptide drug, from insulin to semaglutide to tirzepatide, started with the same application: an Investigational New Drug filing. Here is what the IND process requires and why peptides face distinct review issues.
Regulatory & Legal11 min read
FDA GRAS Status & Peptides: Supplement Pathway
GRAS, or Generally Recognized as Safe, exempts certain substances from FDA premarket approval for food use, but it was never designed as a pathway for peptides with pharmacological activity, and the FDA is now tightening how the term gets used.
Regulatory & Legal17 min read
Peptide Quality Standards: USP, EP, and Beyond
When you look at a certificate of analysis for a peptide and see "98.5% purity by HPLC," what does that number actually mean? Who decided what counts as pure? What tests were run, and against what reference standard?
Regulatory & Legal12 min read
How the DSHEA Affects Peptide Supplements
The Dietary Supplement Health and Education Act of 1994 reshaped the American supplement industry overnight. It gave consumers direct access to vitamins, minerals, herbs, and amino acids without requiring FDA pre-approval.
Regulatory & Legal18 min read
Timeline: History of Peptide Regulation in the US
Peptide regulation in America stretches from the discovery of insulin in 1921 to today's FDA compounding crackdowns. This timeline walks through the disasters, breakthroughs, and political battles that shaped the rules.
Regulatory & Legal14 min read
Consumer Rights When Peptides Are Restricted
When the FDA moved 17 therapeutic peptides to Category 2 of the bulk drug substance list in 2023 and 2024, thousands of patients lost access to treatments their doctors had been prescribing. This guide lays out what legal options remain for patients affected by the restrictions.
Regulatory & Legal14 min read
Canada Peptide Regulations: Access & Legal Status
Canada occupies an unusual position in global peptide regulation. It is about to become the first country where affordable generic semaglutide may be available — Novo Nordisk's key patent expired on January 4, 2026, and Health Canada is actively reviewing generic applications.
Regulatory & Legal14 min read
International Peptide Regulation: EU, UK, Australia
Peptide regulation in the United States gets most of the attention, but the reality is that regulatory frameworks differ dramatically from one country to the next. What is a prescription-only medicine in Australia may be a legal research purchase in the United Kingdom.
Regulatory & Legal14 min read
Peptide Patents & Market Exclusivity Explained
When Novo Nordisk's semaglutide costs $936 per month in the United States and $169 in Japan for the same drug, patents are the reason. When a biosimilar version of a GLP-1 agonist could slash prices by 60–70% but won't reach American pharmacies until the early 2030s, patent strategy is why.
Regulatory & Legal15 min read
DEA Classification of Peptides: Current Status
One of the most common questions in the peptide space is deceptively simple: are peptides controlled substances? The short answer is no — the vast majority of peptides do not appear on any DEA schedule.
Regulatory & Legal16 min read
State Medical Board Positions on Peptide Therapy
If you're a physician prescribing peptide therapy — or a patient receiving it — the FDA is only one of the regulators you need to worry about.
Regulatory & Legal14 min read
FDA Warning Letters to Peptide Companies: Analysis
The FDA's warning letter database tells a story about where peptide regulation is heading — and it's not subtle.
Regulatory & Legal14 min read
Peptide Advertising Regulations: FTC & FDA Rules
If you sell peptides, market a peptide clinic, or run a telehealth platform that prescribes them, the rules about what you can say are stricter than most people realize.
Regulatory & Legal14 min read
Peptide Import Laws: Customs & Personal Use
Ordering peptides from overseas sounds simple until the package does not arrive. Customs and Border Protection screens international shipments for pharmaceutical products, and peptides regularly get flagged, detained, and seized regardless of labeling.
Regulatory & Legal13 min read
Peptides in Professional Sports: Doping Regulations
Every major professional sports league bans peptide hormones and growth hormone secretagogues, but testing frequency, detection methods, and enforcement vary widely between organizations.
Regulatory & Legal14 min read
FDA 503A vs. 503B Compounding: Peptide Implications
503A and 503B pharmacies operate under different sections of federal law, with different oversight, scale, and prescription requirements, and the FDA's narrowing rules affect what each type can compound.
Regulatory & Legal13 min read
Telehealth Peptide Prescriptions: Legal Framework
Getting peptides through telehealth sounds simple. You hop on a video call, describe your goals, and a provider writes a prescription.
Regulatory & Legal14 min read
GLP-1 Drug Shortages: Causes, Status & Alternatives
The GLP-1 shortage that left millions of patients unable to fill Ozempic, Wegovy, Mounjaro, or Zepbound prescriptions stretched from early 2022 through early 2025. This guide covers what caused it, where things stand now, and what options remain.
Regulatory & Legal13 min read
Online Peptide Sales: Legal Risks & Consumer Protection
The internet makes buying peptides easy, but that does not make it safe or legal. This guide covers the legal framework behind online peptide sales, the quality and safety risks consumers face, and how to spot a problematic vendor.
Regulatory & Legal12 min read
Peptides & WADA: Anti-Doping Rules for Athletes
The WADA rules around peptides are strict and specific, banning dozens by name plus catch-all language covering compounds not yet invented, with real consequences for a positive test.
Regulatory & Legal13 min read
GLP-1 Compounding Ban: What Happened & What's Next
For roughly three years, compounding pharmacies filled a gap left by GLP-1 drug shortages, giving patients affordable access to semaglutide, until the FDA declared the shortage over. This article traces what happened and what options remain.
Regulatory & Legal13 min read
BPC-157 Legal Status: FDA Position & Updates
There's one significant problem: BPC-157 is illegal to compound for human use in the United States, banned in competitive sports worldwide, and has never been approved by any government health authority on Earth for any human condition.
Regulatory & Legal12 min read
Research Use Only Peptides: Legal Gray Area Explained
Research use only labels appear on nearly every peptide sold outside a pharmacy, but the legal reality behind those eight words is more complicated than most buyers realize.
Regulatory & Legal14 min read
Peptide Legality Around the World: Global Guide
Every country regulates peptides differently: what you can buy over the counter in Thailand might land you a fine in Australia or require a prescription in Germany. This guide maps peptide regulations across six major regions and what they mean in practice.
Regulatory & Legal20 min read
Are Peptides Legal? State-by-State Guide (2026)
The short answer: it depends on which peptide, how you got it, and what you plan to do with it.
Regulatory & Legal17 min read
FDA Peptide Compounding Crackdown: What It Means
For years, compounding pharmacies were the primary way Americans accessed peptides like BPC-157, thymosin alpha-1, CJC-1295, and ipamorelin. A doctor wrote a prescription. A compounding pharmacy mixed the peptide from bulk powder.
Regulatory & Legal15 min read
Which Peptides Are FDA-Approved? Complete List
When someone mentions "peptides," the conversation often drifts toward research compounds -- BPC-157, CJC-1295, TB-500, and the like. But these are not FDA-approved drugs. They occupy a legal gray area that the FDA has been closing rapidly since 2024.
Regulatory & Legal16 min read
FDA Peptide Regulation: Complete 2025-2026 Timeline
This timeline tracks every major regulatory event in peptide compounding from the first FDA category designations through early 2026, explaining the three-tier classification system that determines what pharmacies can legally compound.